CSI Market
Sign In | Register

Vyne Therapeutics Inc (VYNE) Annual Balance Sheets

Annual · GAAP · USD millions
Access VYNE quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Vyne Therapeutics Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent24.03
Restricted Cash and Cash Equivalents, Current0.00
Marketable Securities, Current SH4.98
Cash & Short-term Investments28.00
Accounts receivable0.00
Inventories0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.00
Total Current Assets30.01
Equipment/Property/Plant Net0.09
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset Current-
Amount Due From Sale Of M S T Franchise-
Prepaid Expense And Other Assets Noncurrent0.06
Operating Lease Right Of Use Asset-
Total Assets30.16
Liabilities
Accounts Payable, Trade, Current1.04
Accrued Liabilities, Current1.35
Other Liabilities, Current0.00
Total Current Liabilities2.40
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent-
Total Liabilities2.40
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock785.41
Retained Earnings / Accumulated Deficit-757.65
Other Equity0.00
Common Stockholder's Equity27.77
Non-controlling interests & other0.00
Total Stockholder's Equity27.77
Liabilities & Stockholder's Equity30.16
4 historic quarters locked

Sign in to unlock the full Vyne Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Vyne Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 27, 2026
  • Source: vyne-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001566044-26-000002

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License